about
Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACT(Expression Attenuation via Constr...
Read More
32.57
0.48
(1.50%)
325.5K
XNAS Volume
XNAS 21 Sep, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Neurogene Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..